Search Page

1

Cite

Share

COR758, a negative allosteric modulator of GABA_B receptors.

Porcu A, Mostallino R, Serra V, Melis M, Sogos V, Beggiato S, Ferraro L, Manetti F, Gianibbi B, Bettler B, Corelli F, Mugnaini C, Castelli MP. Porcu A, et al. Among authors: castelli mp. Neuropharmacology. 2021 May 15;189:108537. doi: 10.1016/j.neuropharm.2021.108537. Epub 2021 Mar 30. Neuropharmacology. 2021. PMID: 33798546

Cite

Share

2

Cite

Share

Sex and Gender Differences in the Effects of Novel Psychoactive Substances.

Fattore L, Marti M, Mostallino R, Castelli MP. Fattore L, et al. Among authors: castelli mp. Brain Sci. 2020 Sep 3;10(9):606. doi: 10.3390/brainsci10090606. Brain Sci. 2020. PMID: 32899299 Free PMC article. Review.

Cite

Share

3

Cite

Share

Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity.

Castelli MP, Madeddu C, Casti A, Casu A, Casti P, Scherma M, Fattore L, Fadda P, Ennas MG. Castelli MP, et al. PLoS One. 2014 May 20;9(5):e98079. doi: 10.1371/journal.pone.0098079. eCollection 2014. PLoS One. 2014. PMID: 24844285 Free PMC article.

Cite

Share

4

Cite

Share

Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances.

Sogos V, Caria P, Porcedda C, Mostallino R, Piras F, Miliano C, De Luca MA, Castelli MP. Sogos V, et al. Among authors: castelli mp. Int J Mol Sci. 2021 Jun 24;22(13):6785. doi: 10.3390/ijms22136785. Int J Mol Sci. 2021. PMID: 34202634 Free PMC article.

Cite

Share

5

Cite

Share

The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidence.

Scherma M, Fattore L, Castelli MP, Fratta W, Fadda P. Scherma M, et al. Among authors: castelli mp. Curr Pharm Des. 2014;20(13):2089-99. doi: 10.2174/13816128113199990429. Epub 2013 Jul 9. Curr Pharm Des. 2014. PMID: 23829365 Review.

Cite

Share

6

Cite

Share

Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlates.

Pintori N, Castelli MP, Miliano C, Simola N, Fadda P, Fattore L, Scherma M, Ennas MG, Mostallino R, Flore G, De Felice M, Sagheddu C, Pistis M, Di Chiara G, De Luca MA. Pintori N, et al. Among authors: castelli mp. Br J Pharmacol. 2021 Sep;178(17):3476-3497. doi: 10.1111/bph.15494. Epub 2021 Jun 29. Br J Pharmacol. 2021. PMID: 33837969 Free PMC article.

Cite

Share

7

Cite

Share

Multi-faceted aspects of gamma-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug of abuse.

Castelli MP. Castelli MP. Mini Rev Med Chem. 2008 Oct;8(12):1188-202. doi: 10.2174/138955708786141025. Mini Rev Med Chem. 2008. PMID: 18855733 Review.

Cite

Share

8

Cite

Share

The new compound GET73, N-[(4-trifluoromethyl)benzyl]4-methoxybutyramide, Regulates hippocampal Aminoacidergic transmission possibly via an allosteric modulation of mGlu5 receptor. Behavioural evidence of its "anti-alcohol" and anxiolytic properties.

Ferraro L, Loche A, Beggiato S, Tomasini MC, Antonelli T, Colombo G, Lobina C, Carai MA, Porcu A, Castelli MP, Clerici F, Borelli AC, Cacciaglia R, Tanganelli S. Ferraro L, et al. Among authors: castelli mp. Curr Med Chem. 2013;20(27):3339-57. doi: 10.2174/09298673113209990167. Curr Med Chem. 2013. PMID: 23862615 Review.

Cite

Share

9

Cite

Share

Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa.

Collu R, Scherma M, Piscitelli F, Giunti E, Satta V, Castelli MP, Verde R, Fratta W, Bisogno T, Fadda P. Collu R, et al. Among authors: castelli mp. Int J Eat Disord. 2019 Nov;52(11):1251-1262. doi: 10.1002/eat.23157. Epub 2019 Aug 27. Int J Eat Disord. 2019. PMID: 31456239

Cite

Share

10

Cite

Share

A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor.

Castelli MP, Pibiri F, Carboni G, Piras AP. Castelli MP, et al. CNS Drug Rev. 2004 Fall;10(3):243-60. doi: 10.1111/j.1527-3458.2004.tb00025.x. CNS Drug Rev. 2004. PMID: 15492774 Free PMC article. Review.

Cite

Share